Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ (15,743)	$ (16,396)
Deferred financing costs	$ (15,101)	$ (16,001)
Common shares, par value (in USD per share)	$ 0.01	$ 0.01
Common shares, shares authorized (in shares)	500,000,000	500,000,000
Common shares, shares issued (in shares)	285,294,874	284,871,943
Common shares, shares outstanding (in shares)	285,294,874	284,871,943